The global keloid treatment market, valued at USD 3.8 billion in 2023, is projected to grow significantly, reaching an ...

A low ejection fraction is a sign of left ventricular dysfunction, called systolic heart failure. Treatment of ICM is ...

View the full release here: "We are honored to be recognized with the Prix Galien Award for Best Digital Health Solution," ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex ...

KMC Hospital in Mangaluru successfully treats Rev Fr Wolfgang Leonhard, a German priest, diagnosed with hypertrophic obstructive cardiomyopathy and complete heart block. The cardiology team implanted ...

A study has found that aficamten is associated with improvements across a range of clinical outcomes in patients with obstructive hypertrophic cardiomyopathy.